Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gisli Jenkins

Showing results (151-160 of 208) with videos related to

Pageof 21
Sort By:
The Lancet. Respiratory Medicine|November 19, 2017
An epithelial biomarker signature for idiopathic pulmonary fibrosis: an analysis from the multicentre PROFILE cohort studyToby M Maher, Eunice Oballa, Juliet K Simpson, et al.
Therapeutic Advances in Respiratory Disease|November 8, 2024
Bexotegrast in people with idiopathic pulmonary fibrosis (IPF): a plain language summary of publication of the INTEGRIS-IPF studyLisa Lancaster, Vincent Cottin, Murali Ramaswamy, et al.
American Journal of Respiratory and Critical Care Medicine|September 6, 2023
Combination of BAL and Computed Tomography Differentiates Progressive and Non-progressive Fibrotic Lung DiseasesJoseph L Barnett, Toby M Maher, Jennifer K Quint, et al.
The Lancet. Respiratory Medicine|July 18, 2024
Cluster analysis of blood biomarkers to identify molecular patterns in pulmonary fibrosis: assessment of a multicentre, prospective, observational cohort with independent validationHernan P Fainberg, Yuben Moodley, Isaac Triguero, et al.
The Lancet. Digital Health|November 4, 2022
Forced vital capacity trajectories in patients with idiopathic pulmonary fibrosis: a secondary analysis of a multicentre, prospective, observational cohortHernan P Fainberg, Justin M Oldham, Philip L Molyneau, et al.
The European Respiratory Journal|May 19, 2018
Optimising experimental research in respiratory diseases: an ERS statementPhilippe Bonniaud, Aurélie Fabre, Nelly Frossard, et al.
Biorxiv : the Preprint Server for Biology|October 27, 2020
Chronic lung diseases are associated with gene expression programs favoring SARS-CoV-2 entry and severityLinh T Bui, Nichelle I Winters, Mei-I Chung, et al.
Chest|September 27, 2025
Specialist Dietary Intervention in Patients With Fibrotic Interstitial Lung Disease Experiencing Unintentional Weight Loss: A Pilot Randomized Controlled TrialRasleen Kahai, Gioele Castelli, Fiammetta Danzo, et al.
Nature Communications|July 15, 2021
Chronic lung diseases are associated with gene expression programs favoring SARS-CoV-2 entry and severityLinh T Bui, Nichelle I Winters, Mei-I Chung, et al.
The European Respiratory Journal|July 18, 2020
Gene expression and <i>in situ</i> protein profiling of candidate SARS-CoV-2 receptors in human airway epithelial cells and lung tissueJennifer A Aguiar, Benjamin J-M Tremblay, Michael J Mansfield, et al.
Pageof 21

Showing results (151-160 of 208) with videos related to

Sort By:
Pageof 21
The Lancet. Respiratory Medicine|November 19, 2017
An epithelial biomarker signature for idiopathic pulmonary fibrosis: an analysis from the multicentre PROFILE cohort studyToby M Maher, Eunice Oballa, Juliet K Simpson, et al.
Therapeutic Advances in Respiratory Disease|November 8, 2024
Bexotegrast in people with idiopathic pulmonary fibrosis (IPF): a plain language summary of publication of the INTEGRIS-IPF studyLisa Lancaster, Vincent Cottin, Murali Ramaswamy, et al.
American Journal of Respiratory and Critical Care Medicine|September 6, 2023
Combination of BAL and Computed Tomography Differentiates Progressive and Non-progressive Fibrotic Lung DiseasesJoseph L Barnett, Toby M Maher, Jennifer K Quint, et al.
The Lancet. Respiratory Medicine|July 18, 2024
Cluster analysis of blood biomarkers to identify molecular patterns in pulmonary fibrosis: assessment of a multicentre, prospective, observational cohort with independent validationHernan P Fainberg, Yuben Moodley, Isaac Triguero, et al.
The Lancet. Digital Health|November 4, 2022
Forced vital capacity trajectories in patients with idiopathic pulmonary fibrosis: a secondary analysis of a multicentre, prospective, observational cohortHernan P Fainberg, Justin M Oldham, Philip L Molyneau, et al.
The European Respiratory Journal|May 19, 2018
Optimising experimental research in respiratory diseases: an ERS statementPhilippe Bonniaud, Aurélie Fabre, Nelly Frossard, et al.
Biorxiv : the Preprint Server for Biology|October 27, 2020
Chronic lung diseases are associated with gene expression programs favoring SARS-CoV-2 entry and severityLinh T Bui, Nichelle I Winters, Mei-I Chung, et al.
Chest|September 27, 2025
Specialist Dietary Intervention in Patients With Fibrotic Interstitial Lung Disease Experiencing Unintentional Weight Loss: A Pilot Randomized Controlled TrialRasleen Kahai, Gioele Castelli, Fiammetta Danzo, et al.
Nature Communications|July 15, 2021
Chronic lung diseases are associated with gene expression programs favoring SARS-CoV-2 entry and severityLinh T Bui, Nichelle I Winters, Mei-I Chung, et al.
The European Respiratory Journal|July 18, 2020
Gene expression and <i>in situ</i> protein profiling of candidate SARS-CoV-2 receptors in human airway epithelial cells and lung tissueJennifer A Aguiar, Benjamin J-M Tremblay, Michael J Mansfield, et al.
Pageof 21